Inhibition of in vitro human lymphocyte response by the pneumococcal toxin pneumolysin - PubMed (original) (raw)

Inhibition of in vitro human lymphocyte response by the pneumococcal toxin pneumolysin

A Ferrante et al. Infect Immun. 1984 Nov.

Abstract

The effects of pneumolysin, a sulfhydryl-activated cytolytic toxin produced by Streptococcus pneumoniae, on the in vitro human lymphocyte response was examined. The toxin, at concentrations of one to five hemolytic units per ml, caused marked inhibition of the response of lymphocytes to concanavalin A, phytohemagglutinin, pokeweed mitogen, and protein A. The response was assessed by measuring both [3H]thymidine incorporation and the ability of lymphocytes to produce immunoglobulins and lymphokine activity. The effects of pneumolysin were irreversible, could be prevented by pretreatment of the toxin with cholesterol, and were not related to a direct cytotoxic effect on the lymphocytes. Pneumolysin appeared to act at the initiation phase of the immune response and had no effect on lymphocytes committed to DNA synthesis or to the synthesis and secretion of immunoglobulins. Furthermore, pneumolysin-mediated inhibition of the lymphocyte response was not due to the inhibition of binding of mitogens to leukocytes and is likely to be related to effects on membrane-mediated signals essential for lymphocyte triggering. This may be one means by which pneumolysin plays a role in the pathogenesis of pneumococcal infections.

PubMed Disclaimer

References

1. J Immunol. 1975 Dec;115(6):1650-6 - PubMed
1. Clin Exp Immunol. 1979 Mar;35(3):443-6 - PubMed
1. Clin Exp Immunol. 1979 Oct;38(1):70-6 - PubMed
1. Infect Immun. 1980 Jan;27(1):97-101 - PubMed
1. Clin Exp Immunol. 1980 Feb;39(2):532-7 - PubMed

Inhibition of in vitro human lymphocyte response by the pneumococcal toxin pneumolysin - PubMed (original) (raw)